Global Gluten Intolerance Treatment Market Size study, by Drug Type, by Indication, by Distribution Channel and Regional Forecasts 2022-2032

Description

Global Gluten Intolerance Treatment Market was valued at approximately USD 596.48 million in 2023 and is anticipated to grow at a remarkable CAGR of 13.98% over the forecast period from 2024 to 2032. Gluten intolerance, also known as non-celiac gluten sensitivity (NCGS), is a condition characterized by adverse reactions to gluten, a protein found in wheat, barley, and rye. Gluten intolerance can lead to symptoms such as bloating, abdominal pain, diarrhea, fatigue, and headaches. Treatment for gluten intolerance primarily involves adopting a gluten-free diet, which means avoiding all foods that contain gluten. This can be challenging as gluten is a common ingredient in many processed foods. People with gluten intolerance must read labels carefully and be aware of potential sources of gluten in their diet. Additionally, some individuals may benefit from working with a dietitian to ensure they maintain a balanced and nutritious diet while avoiding gluten.

The Global Gluten Intolerance Treatment Market is experiencing robust growth driven by growing prevalence of celiac diseases and heightened awareness regarding early diagnosis across the world. As more people worldwide are being diagnosed with gluten intolerance and related disorders, the demand for effective treatment options has surged. This has led to significant advancements in medical research and the development of innovative therapies. Additionally, the rising awareness among the general population about the symptoms and long-term health impacts of gluten intolerance has prompted more individuals to seek medical advice and intervention. Consequently, the market is expanding rapidly, with healthcare providers, pharmaceutical companies, and medical device manufacturers all playing a crucial role in meeting the growing needs of this patient population. Furthermore, the pharmaceutical industry is witnessing increased demand for gluten intolerance treatments, which is propelling market expansion. Moreover, government and non-government expenditure on healthcare and advancements in pharmaceutical research and development is anticipated to create lucrative opportunities for the market. However, high cost of advanced treatments is going to impede the overall demand for the market during the forecast period 2024-2032.

The key regions considered for the Global Gluten Intolerance Treatment Market study includes Asia Pacific, North America, Europe, Latin America, and Rest of the World. In 2023, North America held a dominant position in the gluten sensitivity management landscape and this trend is expected to continue throughout the forecast period. This dominance is due to a higher rate of gluten intolerance diagnoses and the growing demand for advanced-level treatments in the region. On the other hand, Asia Pacific is projected to experience significant market growth due to increased healthcare expenditure by government and non-government agencies aimed at combating celiac disease.

Some of the major market players included in this report are:

Precigen ActoBio
Calypso Biotech SA
Alvine Pharmaceuticals, Inc.
ImmusanT
Artielle ImmunoTherapeutics
FunZyme Biotechnologies
Innovative BioPharma
AMYRA Biotech AG
Vactech Composites Pvt. Ltd.
Alba Therapeutics Corporation
PvP Biologics, Inc.

The detailed segments and sub-segment of the market are explained below:

By Drug Type:

Antihistamines
Epinephrine

By Indication:

Celiac Disease
Dermatitis Herpetiformis
Depression
Gluten Ataxia

By Distribution Channel:

Hospital Pharmacy
Retail Pharmacy
Online Pharmacy

By Region:

North America
U.S.
Canada
Europe
UK
Germany
France
Spain
Italy
ROE
Asia Pacific
China
India
Japan
Australia
South Korea
RoAPAC
Latin America
Brazil
Mexico
RoLA
Middle East & Africa
Saudi Arabia
South Africa
RoMEA

Years considered for the study are as follows:

Historical year - 2022
Base year - 2023
Forecast period - 2024 to 2032

Key Takeaways:

Market Estimates & Forecast for 10 years from 2022 to 2032.
Annualized revenues and regional level analysis for each market segment.
Detailed analysis of geographical landscape with Country level analysis of major regions.
Competitive landscape with information on major players in the market.
Analysis of key business strategies and recommendations on future market approach.
Analysis of competitive structure of the market.
Demand side and supply side analysis of the market

Chapter 1. Global Gluten Intolerance Treatment Market Executive Summary

1.1. Global Gluten Intolerance Treatment Market Size & Forecast (2022-2032)
1.2. Regional Summary
1.3. Segmental Summary
- 1.3.1. By Drug Type
- 1.3.2. By Indication
- 1.3.3. By Distribution Channel
1.4. Key Trends
1.5. Recession Impact
1.6. Analyst Recommendation & Conclusion

Chapter 2. Global Gluten Intolerance Treatment Market Definition and Research Assumptions

2.1. Research Objective
2.2. Market Definition
2.3. Research Assumptions
- 2.3.1. Inclusion & Exclusion
- 2.3.2. Limitations
- 2.3.3. Supply Side Analysis
  - 2.3.3.1. Availability
  - 2.3.3.2. Infrastructure
  - 2.3.3.3. Regulatory Environment
  - 2.3.3.4. Market Competition
  - 2.3.3.5. Economic Viability (Consumer's Perspective)
- 2.3.4. Demand Side Analysis
  - 2.3.4.1. Regulatory frameworks
  - 2.3.4.2. Technological Advancements
  - 2.3.4.3. Environmental Considerations
  - 2.3.4.4. Consumer Awareness & Acceptance
2.4. Estimation Methodology
2.5. Years Considered for the Study
2.6. Currency Conversion Rates

Chapter 3. Global Gluten Intolerance Treatment Market Dynamics

3.1. Market Drivers
- 3.1.1. Growing Prevalence of Celiac Diseases
- 3.1.2. Increase in Awareness Regarding Early Diagnosis
3.2. Market Challenges
- 3.2.1. High Costs of Advanced Treatments
- 3.2.2. Limited Availability of Treatment Options in Emerging Markets
3.3. Market Opportunities
- 3.3.1. Increasing Government and Non-Government Expenditure on Healthcare
- 3.3.2. Advancements in Pharmaceutical Research and Development

Chapter 4. Global Gluten Intolerance Treatment Market Industry Analysis

4.1. Porter's 5 Force Model
- 4.1.1. Bargaining Power of Suppliers
- 4.1.2. Bargaining Power of Buyers
- 4.1.3. Threat of New Entrants
- 4.1.4. Threat of Substitutes
- 4.1.5. Competitive Rivalry
- 4.1.6. Futuristic Approach to Porter's 5 Force Model
- 4.1.7. Porter's 5 Force Impact Analysis
4.2. PESTEL Analysis
- 4.2.1. Political
- 4.2.2. Economical
- 4.2.3. Social
- 4.2.4. Technological
- 4.2.5. Environmental
- 4.2.6. Legal
4.3. Top investment opportunity
4.4. Top winning strategies
4.5. Disruptive Trends
4.6. Industry Expert Perspective
4.7. Analyst Recommendation & Conclusion

Chapter 5. Global Gluten Intolerance Treatment Market Size & Forecasts by Drug Type 2022-2032

5.1. Segment Dashboard
5.2. Global Gluten Intolerance Treatment Market: Drug Type Revenue Trend Analysis, 2022 & 2032 (USD Million)
- 5.2.1. Antihistamines
- 5.2.2. Epinephrine

Chapter 6. Global Gluten Intolerance Treatment Market Size & Forecasts by Indication 2022-2032

6.1. Segment Dashboard
6.2. Global Gluten Intolerance Treatment Market: Indication Revenue Trend Analysis, 2022 & 2032 (USD Million)
- 6.2.1. Celiac Disease
- 6.2.2. Dermatitis Herpetiformis
- 6.2.3. Depression
- 6.2.4. Gluten Ataxia

Chapter 7. Global Gluten Intolerance Treatment Market Size & Forecasts by Distribution Channel 2022-2032

7.1. Segment Dashboard
7.2. Global Gluten Intolerance Treatment Market: Distribution Channel Revenue Trend Analysis, 2022 & 2032 (USD Million)
- 7.2.1. Hospital Pharmacy
- 7.2.2. Retail Pharmacy
- 7.2.3. Online Pharmacy

Chapter 8. Global Gluten Intolerance Treatment Market Size & Forecasts by Region 2022-2032

8.1. North America Gluten Intolerance Treatment Market
- 8.1.1. U.S. Gluten Intolerance Treatment Market
  - 8.1.1.1. Drug Type breakdown size & forecasts, 2022-2032
  - 8.1.1.2. Indication breakdown size & forecasts, 2022-2032
  - 8.1.1.3. Distribution Channel breakdown size & forecasts, 2022-2032
- 8.1.2. Canada Gluten Intolerance Treatment Market
8.2. Europe Gluten Intolerance Treatment Market
- 8.2.1. U.K. Gluten Intolerance Treatment Market
- 8.2.2. Germany Gluten Intolerance Treatment Market
- 8.2.3. France Gluten Intolerance Treatment Market
- 8.2.4. Spain Gluten Intolerance Treatment Market
- 8.2.5. Italy Gluten Intolerance Treatment Market
- 8.2.6. Rest of Europe Gluten Intolerance Treatment Market
8.3. Asia-Pacific Gluten Intolerance Treatment Market
- 8.3.1. China Gluten Intolerance Treatment Market
- 8.3.2. India Gluten Intolerance Treatment Market
- 8.3.3. Japan Gluten Intolerance Treatment Market
- 8.3.4. Australia Gluten Intolerance Treatment Market
- 8.3.5. South Korea Gluten Intolerance Treatment Market
- 8.3.6. Rest of Asia Pacific Gluten Intolerance Treatment Market
8.4. Latin America Gluten Intolerance Treatment Market
- 8.4.1. Brazil Gluten Intolerance Treatment Market
- 8.4.2. Mexico Gluten Intolerance Treatment Market
- 8.4.3. Rest of Latin America Gluten Intolerance Treatment Market
8.5. Middle East & Africa Gluten Intolerance Treatment Market
- 8.5.1. Saudi Arabia Gluten Intolerance Treatment Market
- 8.5.2. South Africa Gluten Intolerance Treatment Market
- 8.5.3. Rest of Middle East & Africa Gluten Intolerance Treatment Market

Chapter 9. Competitive Intelligence

9.1. Key Company SWOT Analysis
9.2. Top Market Strategies
9.3. Company Profiles
- 9.3.1. Precigen ActoBio
  - 9.3.1.1. Key Information
  - 9.3.1.2. Overview
  - 9.3.1.3. Financial (Subject to Data Availability)
  - 9.3.1.4. Product Summary
  - 9.3.1.5. Market Strategies
- 9.3.2. Calypso Biotech SA
- 9.3.3. Alvine Pharmaceuticals, Inc.
- 9.3.4. ImmusanT
- 9.3.5. Artielle ImmunoTherapeutics
- 9.3.6. FunZyme Biotechnologies
- 9.3.7. Innovative BioPharma
- 9.3.8. AMYRA Biotech AG
- 9.3.9. Vactech Composites Pvt. Ltd.
- 9.3.10. Alba Therapeutics Corporation
- 9.3.11. PvP Biologics, Inc.

Chapter 10. Research Process

10.1. Research Process
- 10.1.1. Data Mining
- 10.1.2. Analysis
- 10.1.3. Market Estimation
- 10.1.4. Validation
- 10.1.5. Publishing
10.2. Research Attributes